These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 28062514)

  • 1. Cardiopulmonary exercise testing for detecting pulmonary arterial hypertension in systemic sclerosis.
    Dumitrescu D; Nagel C; Kovacs G; Bollmann T; Halank M; Winkler J; Hellmich M; Grünig E; Olschewski H; Ewert R; Rosenkranz S
    Heart; 2017 May; 103(10):774-782. PubMed ID: 28062514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiopulmonary exercise test predicts right heart catheterization.
    Correale M; Tricarico L; Ferraretti A; Monaco I; Concilio M; Padovano G; Acanfora G; Di Biase M; Brunetti ND
    Eur J Clin Invest; 2017 Dec; 47(12):. PubMed ID: 29082512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The strengths and weaknesses of non-invasive parameters obtained by echocardiography and cardiopulmonary exercise testing in comparison with the hemodynamic assessment by the right heart catheterization in patients with pulmonary hypertension.
    Ptaszyńska-Kopczyńska K; Krentowska A; Sawicka E; Skoneczny A; Jasiewicz M; Knapp M; Musiał WJ; Sobkowicz B; Kamiński KA
    Adv Med Sci; 2017 Mar; 62(1):39-44. PubMed ID: 28187374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension.
    Williams MH; Handler CE; Akram R; Smith CJ; Das C; Smee J; Nair D; Denton CP; Black CM; Coghlan JG
    Eur Heart J; 2006 Jun; 27(12):1485-94. PubMed ID: 16682379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiopulmonary exercise testing in a combined screening approach to individuate pulmonary arterial hypertension in systemic sclerosis.
    Santaniello A; Casella R; Vicenzi M; Rota I; Montanelli G; De Santis M; Bellocchi C; Lombardi F; Beretta L
    Rheumatology (Oxford); 2020 Jul; 59(7):1581-1586. PubMed ID: 31637433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of echocardiography in the identification of an excessive increase in pulmonary arterial pressure in patients with systemic sclerosis.
    Ciurzyński M; Bienias P; Irzyk K; Rymarczyk Z; Kostrubiec M; Szewczyk A; Glińska-Wielochowska M; Zyłkowska J; Kurzyna M; Pruszczyk P
    Kardiol Pol; 2011; 69(1):9-15. PubMed ID: 21267956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study.
    Coghlan JG; Denton CP; Grünig E; Bonderman D; Distler O; Khanna D; Müller-Ladner U; Pope JE; Vonk MC; Doelberg M; Chadha-Boreham H; Heinzl H; Rosenberg DM; McLaughlin VV; Seibold JR;
    Ann Rheum Dis; 2014 Jul; 73(7):1340-9. PubMed ID: 23687283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of exercise capacity in female systemic lupus erythematosus associated pulmonary arterial hypertension patients.
    Pudasaini B; Yang GL; Yang C; Guo J; Yuan P; Wen-Lan Y; Zhang R; Wang L; Zhao QH; Gong SG; Jiang R; Chen TX; Wei X; Liu JM
    BMC Cardiovasc Disord; 2018 Mar; 18(1):56. PubMed ID: 29566672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of the DETECT algorithm for detection of risk of pulmonary arterial hypertension in systemic sclerosis: data from a Czech tertiary centre.
    Soukup T; Pudil R; Kubinova K; Hromadkova L; Dusek J; Tosovsky M; Bradna P; Hrncir Z; Bures J
    Rheumatology (Oxford); 2016 Jan; 55(1):109-14. PubMed ID: 26320140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study.
    Thakkar V; Stevens WM; Prior D; Moore OA; Byron J; Liew D; Patterson K; Hissaria P; Roddy J; Zochling J; Sahhar J; Nash P; Tymms K; Celermajer D; Gabbay E; Youssef P; Proudman SM; Nikpour M
    Arthritis Res Ther; 2012 Jun; 14(3):R143. PubMed ID: 22691291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study.
    Hachulla E; Gressin V; Guillevin L; Carpentier P; Diot E; Sibilia J; Kahan A; Cabane J; Francès C; Launay D; Mouthon L; Allanore Y; Tiev KP; Clerson P; de Groote P; Humbert M
    Arthritis Rheum; 2005 Dec; 52(12):3792-800. PubMed ID: 16320330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventilatory power, a cardiopulmonary exercise testing parameter for the prediction of pulmonary hypertension at right heart catheterization.
    Correale M; Monaco I; Ferraretti A; Tricarico L; Sicuranza M; Gallotta AM; Formica ES; Acanfora G; Di Biase M; Brunetti ND
    Int J Cardiol Heart Vasc; 2020 Jun; 28():100513. PubMed ID: 32346602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of cardiopulmonary exercise test in early diagnosis of pulmonary hypertension in scleroderma patients.
    Sánchez-Aguilera Sánchez-Paulete P; Lázaro Salvador M; Berenguel Senén A; Méndez Perles C; Rodríguez Padial L
    Med Clin (Barc); 2023 Apr; 160(7):283-288. PubMed ID: 36049974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tricuspid annular plane systolic excursion is a robust outcome measure in systemic sclerosis-associated pulmonary arterial hypertension.
    Mathai SC; Sibley CT; Forfia PR; Mudd JO; Fisher MR; Tedford RJ; Lechtzin N; Boyce D; Hummers LK; Housten T; Zaiman AL; Girgis RE; Hassoun PM
    J Rheumatol; 2011 Nov; 38(11):2410-8. PubMed ID: 21965638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Impact of bosentan therapy on stress-induced pulmonary hypertension in patients with systemic sclerosis].
    Volkov AV; Kurmukov IA; Yudkina NN; Glukhova SI; Nikolaeva EV
    Ter Arkh; 2015; 87(1):49-56. PubMed ID: 25823269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of right ventricular reserve on exercise capacity and survival in patients with pulmonary hypertension.
    Blumberg FC; Arzt M; Lange T; Schroll S; Pfeifer M; Wensel R
    Eur J Heart Fail; 2013 Jul; 15(7):771-5. PubMed ID: 23507788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise during cardiac catheterization distinguishes between pulmonary and left ventricular causes of dyspnea in systemic sclerosis patients.
    Hager WD; Collins I; Tate JP; Azrin M; Foley R; Lakshminarayanan S; Rothfield NF
    Clin Respir J; 2013 Jul; 7(3):227-36. PubMed ID: 22789029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiopulmonary exercise testing improves diagnostic specificity in patients with echocardiography-suspected pulmonary hypertension.
    Zhao QH; Wang L; Pudasaini B; Jiang R; Yuan P; Gong SG; Guo J; Xiao Q; Liu H; Wu C; Jing ZC; Liu JM
    Clin Cardiol; 2017 Feb; 40(2):95-101. PubMed ID: 28244596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in pulmonary exercise haemodynamics in scleroderma: a 4-year prospective study.
    Kovacs G; Avian A; Wutte N; Hafner F; Moazedi-Fürst F; Kielhauser S; Aberer E; Brodmann M; Graninger W; Foris V; Olschewski A; Olschewski H
    Eur Respir J; 2017 Jul; 50(1):. PubMed ID: 28705939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France.
    Hachulla E; de Groote P; Gressin V; Sibilia J; Diot E; Carpentier P; Mouthon L; Hatron PY; Jego P; Allanore Y; Tiev KP; Agard C; Cosnes A; Cirstea D; Constans J; Farge D; Viallard JF; Harle JR; Patat F; Imbert B; Kahan A; Cabane J; Clerson P; Guillevin L; Humbert M;
    Arthritis Rheum; 2009 Jun; 60(6):1831-9. PubMed ID: 19479881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.